{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T03:31:53Z","timestamp":1793763113808,"version":"4.6.1"},"reference-count":249,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010028","name":"University of Huddersfield","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010028","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejpb.2026.115259","type":"journal-article","created":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T06:30:51Z","timestamp":1791613851000},"page":"115259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Rational selection of lipid nanocarriers for topical corticosteroid delivery"],"prefix":"10.1016","volume":"229","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-1350-5701","authenticated-orcid":false,"given":"Promise","family":"Adekola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara R.","family":"Conway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1658-148X","authenticated-orcid":false,"given":"Adeola O.","family":"Adebisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2026.115259_b0005","doi-asserted-by":"crossref","unstructured":"Shetty, K., et al., Nano intervention in topical delivery of corticosteroid for psoriasis and atopic dermatitis\u2014a systematic review. Journal of Materials Science: Materials in Medicine 2021 32:8, 2021-07-332(8).","DOI":"10.1007\/s10856-021-06558-y"},{"key":"10.1016\/j.ejpb.2026.115259_b0010","doi-asserted-by":"crossref","unstructured":"Almeida, C., et al., Nanodelivery Strategies for Skin Diseases with Barrier Impairment: Focusing on Ceramides and Glucocorticoids. Nanomaterials 2022, Vol. 12,, 2022-01-14. 12(2).","DOI":"10.3390\/nano12020275"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115259_b0015","article-title":"Development of Betamethasone Dipropionate-Loaded Nanostructured Lipid Carriers for Topical and Transdermal delivery","volume":"18","author":"Hanna","year":"2019","journal-title":"AntiInflammatory Antiallergy Agents Med Chem"},{"key":"10.1016\/j.ejpb.2026.115259_b0020","doi-asserted-by":"crossref","unstructured":"Kalvodov\u00e1, A., et al., The Contest of Nanoparticles: Searching for the Most Effective Topical Delivery of Corticosteroids. Pharmaceutics 2023, Vol. 15,, 2023-02-03. 15(2).","DOI":"10.3390\/pharmaceutics15020513"},{"key":"10.1016\/j.ejpb.2026.115259_b0025","doi-asserted-by":"crossref","DOI":"10.22159\/ijap.2019v11i5.33592","article-title":"Development and evaluation of Clobetasol-loaded solid lipid nanoparticles for topical treatment of psoriasis","author":"Reddy","year":"2019","journal-title":"International Journal of Applied Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115259_b0030","doi-asserted-by":"crossref","unstructured":"Kaur, N., et al., Topical Nanostructured Lipid Carrier Based Hydrogel of Mometasone Furoate for the Treatment of Psoriasis. 2018. p. 133-143.","DOI":"10.2174\/2211738506666180523112513"},{"issue":"10","key":"10.1016\/j.ejpb.2026.115259_b0035","article-title":"Betamethasone Dipropionate Loaded in Nanoliposomes vs conventional Betamethasone Dipropionate Comparative Study of Permeability and Penetrability in Vitro and ex Vivo","volume":"12","author":"Rodriguez","year":"2024","journal-title":"J. Biosci. Med."},{"key":"10.1016\/j.ejpb.2026.115259_b0040","doi-asserted-by":"crossref","unstructured":"Tal\u00e9ns-Visconti, R., et al., New Vehiculation Systems of Mometasone Furoate for the Treatment of Inflammatory Skin Diseases. Pharmaceutics 2022, Vol. 14,, 2022-11-22. 14(12).","DOI":"10.3390\/pharmaceutics14122558"},{"issue":"5","key":"10.1016\/j.ejpb.2026.115259_b0045","article-title":"Ethosome-based Transdermal Drug delivery: its Structural Components, Preparation Techniques, and Therapeutic applications across Metabolic","volume":"17","author":"Almuqbil","year":"2025","journal-title":"Chronic, and Oncological Conditions. Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115259_b0050","first-page":"9(4)","article-title":"Microemulsions and Nanoemulsions in Skin Drug delivery","volume":"5","author":"Souto","year":"2022","journal-title":"Bioengineering"},{"issue":"34","key":"10.1016\/j.ejpb.2026.115259_b0055","doi-asserted-by":"crossref","DOI":"10.1002\/slct.201902007","article-title":"Enhanced Skin Permeation of Hydrocortisone using Nanoemulsion as potential Vehicle","volume":"4","author":"Altamimi","year":"2019","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.ejpb.2026.115259_b0060","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.actbio.2020.08.020","article-title":"Multi-component clobetasol-loaded monolithic lipid-polymer hybrid nanoparticles ameliorate imiquimod-induced psoriasis-like skin inflammation in swiss albino mice","volume":"115","author":"Pukale","year":"2020","journal-title":"Acta Biomater."},{"issue":"5","key":"10.1016\/j.ejpb.2026.115259_b0065","doi-asserted-by":"crossref","DOI":"10.2174\/1567201814666170918163615","article-title":"Preclinical Assessment of Steroidal Nanostructured Lipid Carriers based Gels for Atopic Dermatitis: Optimization and Product Development","volume":"15","author":"Nagaich","year":"2018","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.ejpb.2026.115259_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2024.106275","article-title":"Current status and evidence gap map of betamethasone-loaded nanostructured formulations as cutaneous delivery systems: a scoping review","volume":"101","author":"Toledo","year":"2024","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.ejpb.2026.115259_b0075","article-title":"From lab to industrial development of lipid nanocarriers using quality by design approach","volume":"8","author":"Buya","year":"2024","journal-title":"International Journal of Pharmaceutics: X"},{"key":"10.1016\/j.ejpb.2026.115259_b0080","doi-asserted-by":"crossref","unstructured":"Bouwer, F., et al., Cracking the Skin Barrier: Models and Methods Driving Dermal Drug Delivery. Pharmaceutics 2025, Vol. 17,, 2025-12-09. 17(12).","DOI":"10.3390\/pharmaceutics17121586"},{"key":"10.1016\/j.ejpb.2026.115259_b0085","doi-asserted-by":"crossref","unstructured":"Souto, E.B., et al., Physicochemical and biopharmaceutical aspects influencing skin permeation and role of SLN and NLC for skin drug delivery. Heliyon, 2022 Feb 11. 8(2).","DOI":"10.1016\/j.heliyon.2022.e08938"},{"key":"10.1016\/j.ejpb.2026.115259_b0090","article-title":"Enhancement of stratum corneum lipid structure improves skin barrier function and protects against irritation in adults with dry, eczema\u2010prone skin","volume":"3","author":"Danby","year":"2022","journal-title":"Br. J. Dermatol."},{"issue":"6","key":"10.1016\/j.ejpb.2026.115259_b0095","article-title":"Epidermal thickness at different body sites: relationship to age, gender, pigmentation, blood content, skin type and smoking habits - PubMed","volume":"83","author":"Sandby-M\u00f8ller","year":"2003","journal-title":"Acta Derm. Venereol."},{"issue":"8","key":"10.1016\/j.ejpb.2026.115259_b0100","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.18123","article-title":"Epidermal thickness in healthy humans: a systematic review and meta-analysis","volume":"36","author":"Lintzeri","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.ejpb.2026.115259_b0105","doi-asserted-by":"crossref","unstructured":"Nguyen, A.V., et al., The Dynamics of the Skin\u2019s Immune System. International Journal of Molecular Sciences 2019, Vol. 20, Page 1811, 2019-04-12. 20(8).","DOI":"10.3390\/ijms20081811"},{"key":"10.1016\/j.ejpb.2026.115259_b0110","doi-asserted-by":"crossref","unstructured":"Raharja, A., S. Mahil, and J. Barker, Psoriasis: a brief overview - PubMed. Clinical medicine (London, England), 2021 May. 21(3).","DOI":"10.7861\/clinmed.2021-0257"},{"key":"10.1016\/j.ejpb.2026.115259_b0115","doi-asserted-by":"crossref","DOI":"10.1093\/burnst\/tkad009","article-title":"The application of corticosteroids for pathological scar prevention and treatment: current review and update","volume":"11","author":"Sheng","year":"2023","journal-title":"Burns & Trauma"},{"key":"10.1016\/j.ejpb.2026.115259_b0120","article-title":"Nanocarrier-based dermopharmaceutical formulations for the topical management of atopic dermatitis","volume":"618","author":"Paiva-Santos","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115259_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2014.04.006","article-title":"Penetration of normal, damaged and diseased skin \u2014 an in vitro study on dendritic core\u2013multishell nanotransporters","volume":"185","author":"Alnasif","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2026.115259_b0130","doi-asserted-by":"crossref","unstructured":"Tiwari, D.N., et al., Nanocarriers for Skin Applications: Where Do We Stand? Angewandte Chemie (International Ed. in English), 2021 Oct 1. 61(3).","DOI":"10.1002\/anie.202107960"},{"issue":"4","key":"10.1016\/j.ejpb.2026.115259_b0135","doi-asserted-by":"crossref","DOI":"10.1080\/09546634.2019.1620502","article-title":"Review of international psoriasis guidelines for the treatment of psoriasis: recommendations for topical corticosteroid treatments","volume":"30","author":"Kleyn","year":"2019","journal-title":"J. Dermatol. Treat."},{"issue":"10","key":"10.1016\/j.ejpb.2026.115259_b0140","doi-asserted-by":"crossref","DOI":"10.1111\/cea.14188","article-title":"What is the most effective way to use topical corticosteroids for treating eczema?","volume":"52","author":"Banerjee","year":"2022","journal-title":"Clin Exp Allergy"},{"issue":"5","key":"10.1016\/j.ejpb.2026.115259_b0145","doi-asserted-by":"crossref","DOI":"10.1002\/ski2.268","article-title":"The Long-Term Safety of Topical Corticosteroids in Atopic Dermatitis: a Systematic Review","volume":"3","author":"Harvey","year":"2023","journal-title":"Skin Health and Disease"},{"issue":"6","key":"10.1016\/j.ejpb.2026.115259_b0150","first-page":"337","article-title":"Topical Corticosteroids: Choice and Application","volume":"103","author":"Stacey","year":"2021","journal-title":"Am. Fam. Physician"},{"issue":"1\u20132 Suppl 1","key":"10.1016\/j.ejpb.2026.115259_b0155","first-page":"S16","article-title":"Beyond Skin deep: the Systemic Impact of Topical Corticosteroids in Dermatology","volume":"18","author":"DiRuggiero","year":"2025","journal-title":"J. Clin. Aesthet. Dermatol."},{"key":"10.1016\/j.ejpb.2026.115259_b0160","doi-asserted-by":"crossref","unstructured":"Sevilla, L.M. and P. P\u00e9rez, Roles of the Glucocorticoid and Mineralocorticoid Receptors in Skin Pathophysiology. International Journal of Molecular Sciences, 2018 Jun 29. 19(7).","DOI":"10.3390\/ijms19071906"},{"key":"10.1016\/j.ejpb.2026.115259_b0165","doi-asserted-by":"crossref","unstructured":"Reichardt, S.D., et al., The Role of Glucocorticoids in Inflammatory Diseases. Cells 2021, Vol. 10, Page 2921, 2021-10-28. 10(11).","DOI":"10.3390\/cells10112921"},{"key":"10.1016\/j.ejpb.2026.115259_b0170","doi-asserted-by":"crossref","unstructured":"Bigas, J., et al., Epidermal glucocorticoid and mineralocorticoid receptors act cooperatively to regulate epidermal development and counteract skin inflammation. Cell Death & Disease 2018 9:6, 2018-05-22. 9(6).","DOI":"10.1038\/s41419-018-0673-z"},{"key":"10.1016\/j.ejpb.2026.115259_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2025.112628","article-title":"The role of the mineralocorticoid receptor in skin","volume":"608","author":"Fossas De Mello","year":"2025","journal-title":"Mol. Cell. Endocrinol."},{"issue":"5","key":"10.1016\/j.ejpb.2026.115259_b0180","doi-asserted-by":"crossref","DOI":"10.1093\/bjd\/ljaf028","article-title":"New potency labelling of topical corticosteroids in the UK","volume":"192","author":"Moss","year":"2025","journal-title":"Br. J. Dermatol."},{"issue":"9","key":"10.1016\/j.ejpb.2026.115259_b0185","doi-asserted-by":"crossref","first-page":"651","DOI":"10.31128\/AJGP-07-20-5507","article-title":"Selection of an effective topical corticosteroid","volume":"50","author":"Aung","year":"2021","journal-title":"Aust J Gen Pract"},{"issue":"7","key":"10.1016\/j.ejpb.2026.115259_b0275","doi-asserted-by":"crossref","DOI":"10.1001\/jamadermatol.2022.1706","article-title":"Agreement and Correlation between Different Topical Corticosteroid Potency Classification Systems","volume":"158","author":"Bowie","year":"2022","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.ejpb.2026.115259_b0280","article-title":"Topical Corticosteroids: Pharmacology. a Treatise on Topical Corticosteroids","author":"Kwatra","year":"2018","journal-title":"Dermatology"},{"issue":"2","key":"10.1016\/j.ejpb.2026.115259_b0285","first-page":"135","article-title":"Choosing topical corticosteroids","volume":"79","author":"Ference","year":"2009","journal-title":"Am. Fam. Physician"},{"issue":"10","key":"10.1016\/j.ejpb.2026.115259_b0190","doi-asserted-by":"crossref","DOI":"10.1002\/dta.2412","article-title":"In vitro penetration through the skin layers of topically applied glucocorticoids","volume":"10","author":"Carrer","year":"2018","journal-title":"Drug Test. Anal."},{"issue":"3","key":"10.1016\/j.ejpb.2026.115259_b0195","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2174\/1874467213666200628135552","article-title":"Development and Characterization of a Clobetasol Propionate Nanostructured Lipid Carrier-based Gel for the Treatment of Plaque Psoriasis","volume":"14","author":"Dadwal","year":"2021","journal-title":"Curr. Mol. Pharmacol."},{"key":"10.1016\/j.ejpb.2026.115259_b0200","doi-asserted-by":"crossref","unstructured":"Kim, B.E. and D.Y. Leung, Significance of Skin Barrier Dysfunction in Atopic Dermatitis. Allergy, Asthma & Immunology Research, 2018 Jan 22. 10(3).","DOI":"10.4168\/aair.2018.10.3.207"},{"key":"10.1016\/j.ejpb.2026.115259_b0205","doi-asserted-by":"crossref","DOI":"10.2147\/IJN.S195769","article-title":"Transdermal permeability of triamcinolone acetonide lipid nanoparticle | IJN","volume":"14","author":"Qin","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejpb.2026.115259_b0210","doi-asserted-by":"crossref","unstructured":"Saeki, H., et al., Poor adherence to medication as assessed by the Morisky Medication Adherence Scale-8 and low satisfaction with treatment in 237 psoriasis patients - PubMed. The Journal of dermatology, 2015 Apr. 42(4).","DOI":"10.1111\/1346-8138.12804"},{"issue":"5","key":"10.1016\/j.ejpb.2026.115259_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2005.10.060","article-title":"Adherence with topical treatment is poor compared with adherence with oral agents: Implications for effective clinical use of topical agents","volume":"54","author":"Krejci-Manwaring","year":"2006","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ejpb.2026.115259_b0220","doi-asserted-by":"crossref","unstructured":"Abdel Hay, R.M., et al., Adherence to oral and topical medications among dermatology patients. Archives of Dermatological Research 2025 317:1, 2025-03-20. 317(1).","DOI":"10.1007\/s00403-025-03952-2"},{"key":"10.1016\/j.ejpb.2026.115259_b0225","doi-asserted-by":"crossref","unstructured":"Akombaetwa, N., et al., Current Advances in Lipid Nanosystems Intended for Topical and Transdermal Drug Delivery Applications. Pharmaceutics, 2023 Feb 15. 15(2).","DOI":"10.3390\/pharmaceutics15020656"},{"key":"10.1016\/j.ejpb.2026.115259_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2018.10.017","article-title":"Solid lipid nanoparticles and nanostructured lipid carriers: a review emphasizing on particle structure and drug release","volume":"133","author":"Gordillo-Galeano","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2026.115259_b0235","doi-asserted-by":"crossref","unstructured":"Lazov, C., et al., The Significance of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) in the Treatment of Atopic Dermatitis. Scientia Pharmaceutica 2026, Vol. 94, Page 19, 2026-02-18. 94(1).","DOI":"10.3390\/scipharm94010019"},{"issue":"6","key":"10.1016\/j.ejpb.2026.115259_b0455","doi-asserted-by":"crossref","DOI":"10.1111\/jphp.12543","article-title":"Clobetasol-loaded nanostructured lipid carriers for epidermal targeting","volume":"68","author":"Silva","year":"2016","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2026.115259_b0460","doi-asserted-by":"crossref","unstructured":"Nagaich, U., et al., Nanostructured lipid carriers (NLC) based controlled release topical gel of clobetasol propionate: design and in vivo characterization. Drug Delivery and Translational Research 2016 6:3, 2016-04-12. 6(3).","DOI":"10.1007\/s13346-016-0291-1"},{"key":"10.1016\/j.ejpb.2026.115259_b0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2025.107363","article-title":"Design and optimisation of phospholipid vesicles for topical betamethasone dipropionate","volume":"216","author":"Casula","year":"2026","journal-title":"Eur. J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115259_b0385","doi-asserted-by":"crossref","DOI":"10.2174\/0115672018272012231213100535","article-title":"Overcoming Skin Barrier with Transfersomes: Opportunities, challenges, and applications","volume":"22","author":"Dixena","year":"2024","journal-title":"Curr. Drug Deliv."},{"issue":"4","key":"10.1016\/j.ejpb.2026.115259_b0400","doi-asserted-by":"crossref","first-page":"408","DOI":"10.2174\/1567201817666200804105416","article-title":"Transfersomes: the Ultra-Deformable Carrier System for Non-Invasive delivery of Drug","volume":"18","author":"Gupta","year":"2021","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.ejpb.2026.115259_b0405","doi-asserted-by":"crossref","unstructured":"Akram, M.W., et al., Transfersomes: a Revolutionary Nanosystem for Efficient Transdermal Drug Delivery. 2021. p. 7.","DOI":"10.1208\/s12249-021-02166-9"},{"key":"10.1016\/j.ejpb.2026.115259_b0410","doi-asserted-by":"crossref","unstructured":"Seenivasan, R., et al., Transethosomes: A Comprehensive Review of Ultra-Deformable Vesicular Systems for Enhanced Transdermal Drug Delivery. AAPS PharmSciTech 2025 26:1, 2025-01-17. 26(1).","DOI":"10.1208\/s12249-024-03035-x"},{"key":"10.1016\/j.ejpb.2026.115259_b0415","doi-asserted-by":"crossref","unstructured":"Paiva-Santos, A.C., et al., Ethosomes as Nanocarriers for the Development of Skin Delivery Formulations. Pharmaceutical Research 2021 38:6, 2021-05-25. 38(6).","DOI":"10.1007\/s11095-021-03053-5"},{"issue":"5","key":"10.1016\/j.ejpb.2026.115259_b0420","doi-asserted-by":"crossref","first-page":"993","DOI":"10.3390\/chemistry6050058","article-title":"Ethosomes: a Promising Drug delivery Platform for Transdermal Application","volume":"6","author":"Zhan","year":"2024","journal-title":"Chemistry"},{"key":"10.1016\/j.ejpb.2026.115259_b0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2017.09.006","article-title":"Going skin deep: a direct comparison of penetration potential of lipid-based nanovesicles on the isolated perfused human skin flap model","volume":"121","author":"Ternullo","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115259_b0465","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/08982104.2022.2085742","article-title":"Ethosomes as dermal\/transdermal drug delivery systems: applications, preparation and characterization","volume":"33","author":"Jafari","year":"2023","journal-title":"J. Liposome Res."},{"issue":"11","key":"10.1016\/j.ejpb.2026.115259_b0470","doi-asserted-by":"crossref","DOI":"10.1007\/s13205-021-02978-3","article-title":"Ethosomes-based gel formulation of karanjin for treatment of acne vulgaris: in vitro investigations and preclinical assessment","volume":"11","author":"Ansari","year":"2021","journal-title":"3 Biotech"},{"key":"10.1016\/j.ejpb.2026.115259_b0305","doi-asserted-by":"crossref","unstructured":"Stankovi\u0107, T., et al., Biocompatible lipid nanocarriers for improved skin delivery of fluocinolone acetonide: Physicochemical and in vitro performances. Arhiv za farmaciju. 73(5).","DOI":"10.5937\/arhfarm73-46312"},{"issue":"24","key":"10.1016\/j.ejpb.2026.115259_b0430","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.17130","article-title":"Size-dependent penetration of nanoemulsions into epidermis and hair follicles: implications for transdermal delivery and immunization","volume":"8","author":"Su","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejpb.2026.115259_b0475","doi-asserted-by":"crossref","unstructured":"Das, P., et al., A Comprehensive Review of Nanoemulsion Applications and their Recent Advancements. 2023. p. 209-223.","DOI":"10.2174\/2405461508666221103121439"},{"issue":"21","key":"10.1016\/j.ejpb.2026.115259_b0445","article-title":"Hydrocortisone-Loaded Lipid\u2013Polymer Hybrid Nanoparticles for Controlled Topical delivery: Formulation Design Optimization and In Vitro and In Vivo Appraisal","volume":"8","author":"Alsaidan","year":"2023","journal-title":"ACS Omega, May 19"},{"key":"10.1016\/j.ejpb.2026.115259_b0480","doi-asserted-by":"crossref","unstructured":"Lok, K., H. Loo, and L. Chuah, Topical and transdermal lipid-polymer hybrid nanoparticles (LPN): an integration in advancing dermatological treatments - PubMed. Drug delivery and translational research, 2025 Nov. 15(11).","DOI":"10.1007\/s13346-025-01940-7"},{"key":"10.1016\/j.ejpb.2026.115259_b0500","first-page":"6(1)","article-title":"The effect of Particle size on the Deposition of Solid Lipid Nanoparticles in Different Skin Layers: a Histological Study. Advanced","volume":"17","author":"Adib","year":"2016","journal-title":"Pharm. Bull."},{"key":"10.1016\/j.ejpb.2026.115259_b0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2015.06.020","article-title":"Applications and limitations of lipid nanoparticles in dermal and transdermal drug delivery via the follicular route","volume":"97","author":"Lauterbach","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2026.115259_b0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2015.12.010","article-title":"Nanocarriers for optimizing the balance between interfollicular permeation and follicular uptake of topically applied clobetasol to minimize adverse effects","volume":"223","author":"Mathes","year":"2016","journal-title":"J. Control. Release"},{"issue":"6","key":"10.1016\/j.ejpb.2026.115259_b0515","doi-asserted-by":"crossref","DOI":"10.34172\/bi.2024.30243","article-title":"The impact of particle size of nanostructured lipid carriers on follicular drug delivery: a comprehensive analysis of mouse and human hair follicle penetration","volume":"14","author":"Heydari","year":"2024","journal-title":"Bioimpacts"},{"issue":"4","key":"10.1016\/j.ejpb.2026.115259_b0260","doi-asserted-by":"crossref","DOI":"10.1080\/02652040600612439","article-title":"Polymorphic behaviour of Compritol\u00ae888 ATO as bulk lipid and as SLN and NLC","volume":"23","author":"Souto","year":"2006","journal-title":"J. Microencapsul."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115259_b0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2009.10.022","article-title":"Corticosteroid solubility and lipid polarity control release from solid lipid nanoparticles - PubMed","volume":"390","author":"Jensen","year":"2010","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115259_b0530","doi-asserted-by":"crossref","DOI":"10.1016\/S0939-6411(98)00074-5","article-title":"Correlation between long-term stability of solid lipid nanoparticles (SLN\u2122) and crystallinity of the lipid phase","volume":"47","author":"Freitas","year":"1999","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2026.115259_b0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2025.107491","article-title":"Development and in vivo evaluation of a novel semi-solid nanostructured lipid carrier of fluticasone propionate for the treatment of atopic dermatitis using a quality by design approach","volume":"114","author":"Amasya","year":"2025","journal-title":"J. Drug Delivery Sci. Technol."},{"issue":"4\u20135","key":"10.1016\/j.ejpb.2026.115259_b0325","article-title":"Liposomes and skin: from drug delivery to model membranes","volume":"34","author":"El Maghraby","year":"2008","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115259_b0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2011.01.011","article-title":"Skin penetration behaviour of liposomes as a function of their composition","volume":"79","author":"Gillet","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2026.115259_b0545","doi-asserted-by":"crossref","unstructured":"Chen, Y., et al., Mussel-Inspired Polydopamine Coating Enhances the Intracutaneous Drug Delivery from Nanostructured Lipid Carriers Dependently on a Follicular Pathway. Molecular Pharmaceutics, March 13, 2020.","DOI":"10.1021\/acs.molpharmaceut.9b01240"},{"issue":"42","key":"10.1016\/j.ejpb.2026.115259_b0550","doi-asserted-by":"crossref","DOI":"10.2174\/1381612827666210810091745","article-title":"The Factors determining the Skin Penetration and Cellular Uptake of Nanocarriers: New Hope for Clinical Development","volume":"27","author":"Farjami","year":"2021","journal-title":"Curr. Pharm. Des."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2026.115259_b0555","article-title":"The influence of the crystallinity of lipid nanoparticles on their occlusive properties","volume":"242","author":"Wissing","year":"2002","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115259_b0560","doi-asserted-by":"crossref","DOI":"10.4236\/jcdsa.2015.52008","article-title":"Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) Occlusive effect and Penetration Enhancement Ability","volume":"5","author":"L\u00f3pez-Garc\u00eda","year":"2015","journal-title":"Journal of Cosmetics, Dermatological Sciences and Applications"},{"issue":"4","key":"10.1016\/j.ejpb.2026.115259_b0565","article-title":"A novel formulation strategy for skin occlusion: Semi-solid lipid nanoparticles","volume":"25","author":"\u00c7elikten","year":"2025","journal-title":"Journal of Research in Pharmacy"},{"key":"10.1016\/j.ejpb.2026.115259_b0570","doi-asserted-by":"crossref","unstructured":"Jin, X., et al., Metamorphosis of Topical Semisolid Products\u2014Understanding the Role of Rheological Properties in Drug Permeation under the \u201cin Use\u201d Condition. Pharmaceutics 2023, Vol. 15,, 2023-06-11. 15(6).","DOI":"10.3390\/pharmaceutics15061707"},{"key":"10.1016\/j.ejpb.2026.115259_b0575","doi-asserted-by":"crossref","unstructured":"Jin, X., et al., Topical Semisolid Products\u2014Understanding the Impact of Metamorphosis on Skin Penetration and Physicochemical Properties. Pharmaceutics 2022, Vol. 14,, 2022-11-17. 14(11).","DOI":"10.3390\/pharmaceutics14112487"},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2026.115259_b0580","article-title":"Nanocarriers for dermal drug delivery: Influence of preparation method, carrier type and rheological properties","volume":"437","author":"Schwarz","year":"2012","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.ejpb.2026.115259_b0240","doi-asserted-by":"crossref","DOI":"10.1159\/000324053","article-title":"Drug Release and Skin Penetration from Solid Lipid Nanoparticles and a Base Cream: a Systematic Approach from a Comparison of three Glucocorticoids","volume":"24","author":"Schlupp","year":"2011","journal-title":"Skin Pharmacol. Physiol."},{"issue":"8","key":"10.1016\/j.ejpb.2026.115259_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2025.103876","article-title":"Sustained release of betamethasone from solid lipid nanoparticles loaded polymeric hydrogels with natural emollient: one step closer to effective topical therapy for atopic dermatitis","volume":"114","author":"Athavale","year":"2025","journal-title":"J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.ejpb.2026.115259_b0250","doi-asserted-by":"crossref","DOI":"10.1080\/02652048.2021.1887383","article-title":"Fluticasone propionate\u2013loaded solid lipid nanoparticles with augmented anti-inflammatory activity: optimisation, characterisation and pharmacodynamic evaluation on rats","volume":"38","author":"Desoqi","year":"2021","journal-title":"J. Microencapsul."},{"issue":"3","key":"10.1016\/j.ejpb.2026.115259_b0255","doi-asserted-by":"crossref","DOI":"10.1080\/17425247.2020.1727883","article-title":"SLN and NLC for topical, dermal, and transdermal drug delivery","volume":"17","author":"Souto","year":"2020","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejpb.2026.115259_b0265","doi-asserted-by":"crossref","unstructured":"Ghasemiyeh, P. and S. Mohammadi-Samani, Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages. Research in Pharmaceutical Sciences, August 2018. 13(4).","DOI":"10.4103\/1735-5362.235156"},{"issue":"6","key":"10.1016\/j.ejpb.2026.115259_b0290","article-title":"Solid Lipid Nanoparticles vs","volume":"15","author":"Viegas","year":"2023","journal-title":"Nanostructured Lipid Carriers: A Comparative Review. Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115259_b0295","doi-asserted-by":"crossref","unstructured":"Khan, S., A. Sharma, and V. Jain, An Overview of Nanostructured Lipid Carriers and its Application in Drug Delivery through Different Routes. Advanced Pharmaceutical Bulletin, 2022 Sep 18. 13(3).","DOI":"10.34172\/apb.2023.056"},{"key":"10.1016\/j.ejpb.2026.115259_b0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2025.107766","article-title":"Nanostructured lipid carrier-incorporated hybrid hydrogels for enhanced betamethasone delivery in atopic dermatitis","volume":"115","author":"Barbosa","year":"2026","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.ejpb.2026.115259_b0310","doi-asserted-by":"crossref","unstructured":"Choudhury, A., et al., Strategic advances in liposomes technology: translational paradigm in transdermal delivery for skin dermatosis. Journal of Nanobiotechnology 2025 23:1, 2025-08-21. 23(1).","DOI":"10.1186\/s12951-025-03660-z"},{"issue":"5","key":"10.1016\/j.ejpb.2026.115259_b0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e09394","article-title":"Liposomes: structure, composition, types, and clinical applications","volume":"8","author":"Nsairat","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.ejpb.2026.115259_b0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2019.01.028","article-title":"Effects of surface charge and flexibility of liposomes on dermal drug delivery","volume":"50","author":"Ibaraki","year":"2019","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.ejpb.2026.115259_b0330","doi-asserted-by":"crossref","unstructured":"Peralta, M.F., et al., Liposomes can both enhance or reduce drugs penetration through the skin. Scientific Reports, 2018 Sep 5. 8(1).","DOI":"10.1038\/s41598-018-31693-y"},{"issue":"11","key":"10.1016\/j.ejpb.2026.115259_b0340","doi-asserted-by":"crossref","DOI":"10.1093\/jpp\/rgab082","article-title":"Vesicular drug delivery for the treatment of topical disorders: current and future perspectives - PubMed","volume":"73","author":"Witika","year":"2021","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2026.115259_b0345","doi-asserted-by":"crossref","unstructured":"Touitou, E., et al., Topical Administration of Drugs Incorporated in Carriers Containing Phospholipid Soft Vesicles for the Treatment of Skin Medical Conditions. Pharmaceutics 2021, Vol. 13, Page 2129, 2021-12-10. 13(12).","DOI":"10.3390\/pharmaceutics13122129"},{"key":"10.1016\/j.ejpb.2026.115259_b0350","doi-asserted-by":"crossref","unstructured":"Touitou, E., et al., The Evolution of Emerging Nanovesicle Technologies for Enhanced Delivery of Molecules into and across the Skin. Pharmaceutics 2024, Vol. 16, Page 267, 2024-02-13. 16(2).","DOI":"10.3390\/pharmaceutics16020267"},{"key":"10.1016\/j.ejpb.2026.115259_b0355","doi-asserted-by":"crossref","unstructured":"Natsheh, H., et al., Phospholipid Vesicles for Dermal\/Transdermal and Nasal Administration of Active Molecules: The Effect of Surfactants and Alcohols on the Fluidity of Their Lipid Bilayers and Penetration Enhancement Properties. Molecules 2020, Vol. 25, Page 2959, 2020-06-27. 25(13).","DOI":"10.3390\/molecules25132959"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115259_b0360","article-title":"Development, characterization, and skin delivery studies of related ultradeformable vesicles: transfersomes, ethosomes, and transethosomes","volume":"10","author":"Ascenso","year":"2015","journal-title":"Int. J. Nanomed."},{"issue":"7","key":"10.1016\/j.ejpb.2026.115259_b0365","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202305468","article-title":"Transdermal Transfersome Nanogels Control Hypertrophic Scar Formation via Synergy of Macrophage Phenotype\u2010Switching and Anti\u2010Fibrosis effect","volume":"11","author":"Chen","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ejpb.2026.115259_b0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.126492","article-title":"Development of a FU\/TA ethosome-based polymeric nanocomposite film for sustained, non-invasive hypertrophic scar therapy: from bench to clinic","volume":"689","author":"Abdi","year":"2026","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115259_b0375","doi-asserted-by":"crossref","unstructured":"Medhi, J., et al., The future of vesicular drug delivery: transferosomes in therapeutic advancement\u2014applications, innovations and challenges. BioMedical Engineering OnLine, 2025 Dec 2. 25(1).","DOI":"10.1186\/s12938-025-01490-6"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115259_b0380","doi-asserted-by":"crossref","DOI":"10.1080\/1061186X.2024.2402750","article-title":"An overview of phospholipid enriched-edge activator-based vesicle nanocarriers: new paradigms to treat skin cancer","volume":"33","author":"Jahan","year":"2025","journal-title":"J. Drug Target."},{"issue":"9","key":"10.1016\/j.ejpb.2026.115259_b0390","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12090855","article-title":"Transfersomes: a Promising Nanoencapsulation Technique for Transdermal Drug delivery","volume":"12","author":"Opatha","year":"2020","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115259_b0395","doi-asserted-by":"crossref","DOI":"10.1080\/20022727.2017.1325708","article-title":"Transfersomes as versatile and flexible nano-vesicular carriers in skin cancer therapy: the state of the art","volume":"8","author":"Rai","year":"2017","journal-title":"Nano Rev. Exp."},{"key":"10.1016\/j.ejpb.2026.115259_b0435","doi-asserted-by":"crossref","unstructured":"Preeti, et al., Nanoemulsion: An Emerging Novel Technology for Improving the Bioavailability of Drugs. Scientifica, 2023 Oct 28. 2023.","DOI":"10.1155\/2023\/6640103"},{"key":"10.1016\/j.ejpb.2026.115259_b0440","doi-asserted-by":"crossref","unstructured":"Lal, D.K., et al., An Overview of Nanoemulgels for Bioavailability Enhancement in Inflammatory Conditions via Topical Delivery. Pharmaceutics 2023, Vol. 15, Page 1187, 2023-04-07. 15(4).","DOI":"10.3390\/pharmaceutics15041187"},{"key":"10.1016\/j.ejpb.2026.115259_b0450","doi-asserted-by":"crossref","unstructured":"Jain, S., et al., Lipid\u2013Polymer Hybrid Nanosystems: A Rational Fusion for Advanced Therapeutic Delivery. Journal of Functional Biomaterials, 2023 Aug 23. 14(9).","DOI":"10.3390\/jfb14090437"},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2026.115259_b0485","article-title":"Lipid nanocarriers as skin drug delivery systems: Properties, mechanisms of skin interactions and medical applications","volume":"535","author":"Sala","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115259_b0490","doi-asserted-by":"crossref","unstructured":"Mekasha, Y.T., et al., Application of quality by design principles in topical semisolid formulations development: a systematic review of CQA, DoE, and control strategies. AAPS Open 2026 12:1, 2026-08-03. 12(1).","DOI":"10.1186\/s41120-026-00174-2"},{"key":"10.1016\/j.ejpb.2026.115259_b0495","doi-asserted-by":"crossref","unstructured":"Angelo, T., et al., Effect of physical stimuli on hair follicle deposition of clobetasol-loaded Lipid Nanocarriers. Scientific Reports 2020 10:1, 2020-01-13. 10(1).","DOI":"10.1038\/s41598-019-56760-w"},{"key":"10.1016\/j.ejpb.2026.115259_b0520","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121273","article-title":"Mapping hair follicle-targeted delivery by particle systems: what has science accomplished so far? - PubMed","volume":"610","author":"Costa","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"7","key":"10.1016\/j.ejpb.2026.115259_b0525","doi-asserted-by":"crossref","DOI":"10.1080\/10837450.2019.1596133","article-title":"Cyproterone acetate-loaded nanostructured lipid carriers: effect of particle size on skin penetration and follicular targeting","volume":"24","author":"Ghasemiyeh","year":"2019","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ejpb.2026.115259_b0585","doi-asserted-by":"crossref","unstructured":"Ganesan, P. and D. Narayanasamy, Lipid nanoparticles: Different preparation techniques, characterization, hurdles, and strategies for the production of solid lipid nanoparticles and nanostructured lipid carriers for oral drug delivery. 2017. p. 37-56.","DOI":"10.1016\/j.scp.2017.07.002"},{"issue":"2\u20133","key":"10.1016\/j.ejpb.2026.115259_b0590","article-title":"Solid lipid nanoparticles: production, characterization and applications","volume":"47","author":"Mehnert","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"22","key":"10.1016\/j.ejpb.2026.115259_b0595","doi-asserted-by":"crossref","DOI":"10.2174\/0929867326666190624155938","article-title":"Formulating SLN and NLC as innovative Drug delivery Systems for Non-Invasive Routes of Drug Administration","volume":"27","author":"Fonseca-Santos","year":"2020","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejpb.2026.115259_b0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2016.10.021","article-title":"Effect of drug solubility and lipid carrier on drug release from lipid nanoparticles for dermal delivery","volume":"110","author":"Zoubari","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2026.115259_b0605","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2017.04.003","article-title":"Influence of state and crystallinity of lipid matrix on physicochemical properties and permeation of capsaicin-loaded lipid nanoparticles for topical delivery","volume":"39","author":"Teeranachaideekul","year":"2017","journal-title":"J. Drug Delivery Sci. Technol."},{"issue":"2\u20133","key":"10.1016\/j.ejpb.2026.115259_b0610","article-title":"Corticosteroid dermal delivery with skin-lipid liposomes","volume":"44","author":"Fresta","year":"1997","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2026.115259_b0615","doi-asserted-by":"crossref","DOI":"10.1080\/01932691.2026.2625036","article-title":"Ultra-deformable lipid-based nanocarrier: a new frontier in dermatological drug delivery with improved biomimetic attributes","author":"Malhan","year":"2026","journal-title":"J. Dispers. Sci. Technol."},{"key":"10.1016\/j.ejpb.2026.115259_b0620","article-title":"Ethosomes and Transfersomes: Principles","author":"Garg","year":"2017","journal-title":"Perspectives and Practices."},{"key":"10.1016\/j.ejpb.2026.115259_b0625","doi-asserted-by":"crossref","DOI":"10.1016\/j.onano.2025.100251","article-title":"Entrapment efficiency methodology for lipid nanoparticles \u2013 a literature review","volume":"24","author":"Baltz","year":"2025","journal-title":"OpenNano"},{"key":"10.1016\/j.ejpb.2026.115259_b0630","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2026.1794154","article-title":"Advanced analysis of formulation parameters governing encapsulation efficiency: drug delivery system","volume":"14","author":"Sumayli","year":"2026","journal-title":"Front. Chem."},{"key":"10.1016\/j.ejpb.2026.115259_b0635","article-title":"Scalable microfluidic fabrication of optimized phospholipid nanocarriers for enhanced topical bioavailability: Analytical QbD integration and ex vivo skin permeation assessment","volume":"11","author":"Bucciarelli","year":"2026","journal-title":"International Journal of Pharmaceutics: X"},{"key":"10.1016\/j.ejpb.2026.115259_b0640","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1333986","article-title":"Topical drug delivery strategies for enhancing drug effectiveness by skin barriers, drug delivery systems and individualized dosing","volume":"14","author":"Zhao","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejpb.2026.115259_b0645","doi-asserted-by":"crossref","unstructured":"Stefanov, S.R. and V.Y. Andonova, Lipid Nanoparticulate Drug Delivery Systems: Recent Advances in the Treatment of Skin Disorders. Pharmaceuticals (Basel), 2021. 14(11).","DOI":"10.3390\/ph14111083"},{"key":"10.1016\/j.ejpb.2026.115259_b0650","doi-asserted-by":"crossref","unstructured":"Matos, B., et al., Follicle-Targeted Delivery of Betamethasone and Minoxidil Co-Entrapped in Polymeric and Lipid Nanoparticles for Topical Alopecia Areata Treatment - PubMed. Pharmaceuticals (Basel, Switzerland), 09\/19\/2023. 16(9).","DOI":"10.3390\/ph16091322"},{"key":"10.1016\/j.ejpb.2026.115259_b0655","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2023.09.007","article-title":"Prediction of the penetration depth of multi-lamellar liposomes in artificial skin. Application to the vectorization of corticosteroid in human skin","volume":"191","author":"Bernasqu\u00e9","year":"2023","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2026.115259_b0660","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2026.127254","article-title":"Clobetasol-loaded core-active lipid nanoparticles: an enhanced therapy for inflammatory skin conditions","volume":"702","author":"Madariaga-Burgos","year":"2026","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115259_b0665","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/08982104.2023.2221354","article-title":"A comprehensive review on transethosomes as a novel vesicular approach for drug delivery through transdermal route","volume":"34","author":"Munir","year":"2024","journal-title":"J. Liposome Res."},{"issue":"3","key":"10.1016\/j.ejpb.2026.115259_b0670","doi-asserted-by":"crossref","DOI":"10.1016\/S0168-3659(96)01566-0","article-title":"Transfersomes-mediated transepidermal delivery improves the regio-specificity and biological activity of corticosteroids in vivo","volume":"45","author":"Cevc","year":"1997","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2026.115259_b0675","doi-asserted-by":"crossref","unstructured":"Esposito, E., et al., Ex Vivo Evaluation of Ethosomes and Transethosomes Applied on Human Skin: A Comparative Study. International Journal of Molecular Sciences 2022, Vol. 23, Page 15112, 2022-12-01. 23(23).","DOI":"10.3390\/ijms232315112"},{"key":"10.1016\/j.ejpb.2026.115259_b0680","doi-asserted-by":"crossref","unstructured":"Alvarez-Figueroa, M.J., et al., Effect of zeta potential of innovative lipid nanocapsules on triamcinolone transdermal delivery. Drug Delivery and Translational Research 2022 12:11, 2022-03-13. 12(11).","DOI":"10.1007\/s13346-022-01134-5"},{"issue":"3","key":"10.1016\/j.ejpb.2026.115259_b0685","doi-asserted-by":"crossref","DOI":"10.1159\/000270381","article-title":"Disposition of Charged Nanoparticles after their Topical Application to the Skin","volume":"23","author":"Wu","year":"2010","journal-title":"Skin Pharmacol. Physiol."},{"key":"10.1016\/j.ejpb.2026.115259_b0690","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2023.02.006","article-title":"Skin drug delivery using lipid vesicles: a starting guideline for their development","volume":"355","author":"Guillot","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2026.115259_b0695","doi-asserted-by":"crossref","unstructured":"Safta, D.A., C. Bogdan, and M.-L. Moldovan, SLNs and NLCs for Skin Applications: Enhancing the Bioavailability of Natural Bioactives. Pharmaceutics, 2024 Sep 28. 16(10).","DOI":"10.3390\/pharmaceutics16101270"},{"issue":"2","key":"10.1016\/j.ejpb.2026.115259_b0700","doi-asserted-by":"crossref","DOI":"10.1046\/j.1523-1747.2003.12046.x","article-title":"Hydration Disrupts Human Stratum Corneum Ultrastructure","volume":"120","author":"Warner","year":"2003","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115259_b0705","article-title":"Effect of compositions in nanostructured lipid carriers (NLC) on skin | IJN","volume":"8","author":"Loo","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejpb.2026.115259_b0710","doi-asserted-by":"crossref","unstructured":"Montenegro, L., et al., Resveratrol-Loaded Lipid Nanocarriers: Correlation between In Vitro Occlusion Factor and In Vivo Skin Hydrating Effect. Pharmaceutics 2017, Vol. 9,, 2017-12-10. 9(4).","DOI":"10.3390\/pharmaceutics9040058"},{"key":"10.1016\/j.ejpb.2026.115259_b0715","first-page":"11(4)","article-title":"Lipid Nanoparticles and their Hydrogel Composites for Drug delivery","volume":"Nov 1","author":"Desfran\u00e7ois","year":"2018","journal-title":"A Review. Pharmaceuticals"},{"issue":"6","key":"10.1016\/j.ejpb.2026.115259_b0720","doi-asserted-by":"crossref","DOI":"10.1080\/20415990.2025.2483151","article-title":"Advantages and therapeutic applications of different semisolids as vehicles for nano-based systems","volume":"16","author":"Shalaby","year":"2025","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.ejpb.2026.115259_b0725","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2024.114305","article-title":"Influence of type of vehicle on dermal penetration efficacy of hydrophilic, amphiphilic, lipophilic model drugs","volume":"200","author":"Kaushik","year":"2024","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115259_b0730","doi-asserted-by":"crossref","DOI":"10.1021\/mp500542a","article-title":"Drug Permeation through Skin is Inversely Correlated with Carrier Gel Rigidity","volume":"12","author":"Nguyen","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2026.115259_b0735","doi-asserted-by":"crossref","unstructured":"Deacon, B.N., et al., Computational Modelling of the Impact of Evaporation on In-Vitro Dermal Absorption. Pharmaceutical Research 2024 41:10, 2024-10-07. 41(10).","DOI":"10.1007\/s11095-024-03779-y"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115259_b0740","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2004.02.015","article-title":"Evaluation of the physical stability of SLN and NLC before and after incorporation into hydrogel formulations","volume":"58","author":"Souto","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"3","key":"10.1016\/j.ejpb.2026.115259_b0745","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2004.04.009","article-title":"Liquid and semisolid SLN\u2122 dispersions for topical application: rheological characterization","volume":"58","author":"Lippacher","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115259_b0750","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1756","article-title":"Nanocarrier\u2010hydrogel composite delivery systems for precision drug release","volume":"14","author":"Kass","year":"2022","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.ejpb.2026.115259_b0755","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2026.108393","article-title":"Lipid-based nanocarriers for anticancer drug delivery: Mechanistic advances, translational challenges, and implications for generic development","volume":"122","author":"Rahman","year":"2026","journal-title":"J. Drug Delivery Sci. Technol."},{"issue":"4","key":"10.1016\/j.ejpb.2026.115259_b0760","doi-asserted-by":"crossref","DOI":"10.1039\/D6PM00126B","article-title":"Lipid phase organization controls drug partitioning and release across lipid nanocarriers","volume":"3","author":"Pires","year":"2026","journal-title":"RSC Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115259_b0765","unstructured":"Rosso, J.D., et al., Understanding the Epidermal Barrier in Healthy and Compromised Skin: Clinically Relevant Information for the Dermatology Practitioner: Proceedings of an Expert Panel Roundtable Meeting. J Clin Aesthet Dermatol, 2016. 9(4 Suppl 1): p. S2-s8."},{"issue":"22","key":"10.1016\/j.ejpb.2026.115259_b0770","doi-asserted-by":"crossref","first-page":"19145","DOI":"10.1021\/acsomega.2c08016","article-title":"New Insights in Topical Drug delivery for Skin Disorders: from a Nanotechnological Perspective","volume":"8","author":"Raina","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejpb.2026.115259_b0775","doi-asserted-by":"crossref","unstructured":"Oliveira, R. and I.F. Almeida, Patient-Centric Design of Topical Dermatological Medicines - PubMed. Pharmaceuticals (Basel, Switzerland), 04\/19\/2023. 16(4).","DOI":"10.3390\/ph16040617"},{"key":"10.1016\/j.ejpb.2026.115259_b0780","doi-asserted-by":"crossref","unstructured":"Chang, R.-K., et al., Generic Development of Topical Dermatologic Products: Formulation Development, Process Development, and Testing of Topical Dermatologic Products. The AAPS Journal, 2012 Oct 9. 15(1).","DOI":"10.1208\/s12248-012-9411-0"},{"key":"10.1016\/j.ejpb.2026.115259_b0785","doi-asserted-by":"crossref","unstructured":"Gorzelanny, C., et al., Skin Barriers in Dermal Drug Delivery: Which Barriers Have to Be Overcome and How Can We Measure Them? Pharmaceutics, 2020 Jul 20. 12(7).","DOI":"10.3390\/pharmaceutics12070684"},{"key":"10.1016\/j.ejpb.2026.115259_b0855","doi-asserted-by":"crossref","unstructured":"Sun, W., et al., Leveraging Physiology for Precision Drug Delivery. Physiological Reviews, 2016 Nov 09. 97(1).","DOI":"10.1152\/physrev.00015.2016"},{"issue":"11","key":"10.1016\/j.ejpb.2026.115259_b0860","doi-asserted-by":"crossref","DOI":"10.1002\/bcp.70102","article-title":"Characterizing local and systemic exposure to clobetasol propionate in healthy subjects and patients with atopic dermatitis","volume":"91","author":"Duong","year":"2025","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejpb.2026.115259_b0865","doi-asserted-by":"crossref","unstructured":"Tapfumaneyi, P., et al., Solute\u2013Vehicle\u2013Skin Interactions and Their Contribution to Pharmacokinetics of Skin Delivery. Pharmaceutics 2025, Vol. 17,, 2025-06-10. 17(6).","DOI":"10.3390\/pharmaceutics17060764"},{"key":"10.1016\/j.ejpb.2026.115259_b0870","unstructured":"Alsk\u00e4r, L.C., C.J.H. Porter, and C.A.S. Bergstr\u00f6m, Tools for Early Prediction of Drug Loading in Lipid-Based."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115259_b0875","volume":"13","year":"2016","journal-title":"Mol. Pharm."},{"issue":"6","key":"10.1016\/j.ejpb.2026.115259_b0880","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1007\/s13346-021-01021-5","article-title":"Are lipid nanoparticles really superior? a holistic proof of concept study","volume":"12","author":"Wiemann","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"issue":"12","key":"10.1016\/j.ejpb.2026.115259_b0885","doi-asserted-by":"crossref","DOI":"10.1002\/jps.24666","article-title":"Minimization of local and Systemic adverse Effects of Topical Glucocorticoids by Nanoencapsulation: In Vivo Safety of Hydrocortisone\u2013Hydroxytyrosol Loaded Chitosan Nanoparticles","volume":"104","author":"Siddique","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115259_b0890","doi-asserted-by":"crossref","unstructured":"Pensado, A., et al., Assessment of dermal bioavailability: predicting the input function for topical glucocorticoids using stratum corneum sampling. Drug Delivery and Translational Research 2021 12:4, 2021-10-01. 12(4).","DOI":"10.1007\/s13346-021-01064-8"},{"issue":"8","key":"10.1016\/j.ejpb.2026.115259_b0790","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21082867","article-title":"Skin Barrier Abnormalities and Immune Dysfunction in Atopic Dermatitis","volume":"21","author":"Yang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.ejpb.2026.115259_b0795","doi-asserted-by":"crossref","DOI":"10.20344\/amp.11963","article-title":"Update on Atopic Dermatitis","volume":"32","author":"Torres","year":"2019","journal-title":"Acta M\u00e9dica Portuguesa"},{"key":"10.1016\/j.ejpb.2026.115259_b0800","first-page":"30(5)","article-title":"Utility of transepidermal water loss\u2010stratum corneum hydration ratio in atopic dermatitis","volume":"May 20","author":"Sreekantaswamy","year":"2024","journal-title":"Skin Res. Technol."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115259_b0805","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdermsci.2025.04.001","article-title":"Stratum corneum pH and ceramides: Key regulators and biomarkers of skin barrier function in atopic dermatitis","volume":"118","author":"Sakai","year":"2025","journal-title":"J. Dermatol. Sci."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115259_b0810","doi-asserted-by":"crossref","DOI":"10.1016\/j.anai.2023.09.009","article-title":"Filaggrin and beyond: New insights into the skin barrier in atopic dermatitis and allergic diseases, from genetics to therapeutic perspectives","volume":"132","author":"Stefanovic","year":"2024","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.ejpb.2026.115259_b0815","doi-asserted-by":"crossref","unstructured":"Pala, V., et al., The Central Role of Th2 Immune Response in Inflammatory Dermatoses: From Pathogenesis to Targeted Therapies. International Journal of Molecular Sciences 2025, Vol. 26,, 2025-11-04. 26(21).","DOI":"10.3390\/ijms262110720"},{"key":"10.1016\/j.ejpb.2026.115259_b0820","doi-asserted-by":"crossref","DOI":"10.1080\/09546634.2020.1789050","article-title":"Vehicles for atopic dermatitis therapies: more than just a placebo","author":"Danby","year":"2022","journal-title":"J. Dermatol. Treat."},{"key":"10.1016\/j.ejpb.2026.115259_b0825","doi-asserted-by":"crossref","unstructured":"Orsmond, A., et al., Skin Barrier Dysregulation in Psoriasis. International Journal of Molecular Sciences, 2021 Oct 7. 22(19).","DOI":"10.3390\/ijms221910841"},{"key":"10.1016\/j.ejpb.2026.115259_b0830","doi-asserted-by":"crossref","unstructured":"Chan, J.J., Psoriasis: an update on topical and systemic therapies. Australian Prescriber, 2025 Jun 10. 48(3).","DOI":"10.18773\/austprescr.2025.026"},{"issue":"2","key":"10.1016\/j.ejpb.2026.115259_b0835","first-page":"22","article-title":"Topical Corticosteroid Therapy for Psoriasis-a Review of Clobetasol Propionate 0.025% Cream and the Clinical Relevance of Penetration Modification","volume":"13","author":"Del Rosso","year":"2020","journal-title":"J. Clin. Aesthet. Dermatol."},{"key":"10.1016\/j.ejpb.2026.115259_b0840","doi-asserted-by":"crossref","unstructured":"Morsy, H., et al., Optical coherence tomography imaging of psoriasis vulgaris: correlation with histology and disease severity. Archives of Dermatological Research 2009 302:2, 2009-11-06. 302(2).","DOI":"10.1007\/s00403-009-1000-4"},{"issue":"2","key":"10.1016\/j.ejpb.2026.115259_b0845","article-title":"Measurement of Epidermal Thickness in Normal Skin and Psoriasis with High-Frequency Ultrasound","volume":"1","author":"Hermann","year":"1988","journal-title":"Skin Pharmacol. Physiol."},{"key":"10.1016\/j.ejpb.2026.115259_b0850","doi-asserted-by":"crossref","unstructured":"Welzel, J., et al., Optical coherence tomography in contact dermatitis and psoriasis. Archives of Dermatological Research 2003 295:2, 2003-04-02. 295(2).","DOI":"10.1007\/s00403-003-0390-y"},{"key":"10.1016\/j.ejpb.2026.115259_b0895","doi-asserted-by":"crossref","unstructured":"Jandang, W., et al., Quality by Design-Based Scale-Up and Industrial Development of Turmeric Extract-Loaded Nanostructured Lipid Carriers. Pharmaceutics 2026, Vol. 18,, 2026-04-16. 18(4).","DOI":"10.3390\/pharmaceutics18040492"},{"key":"10.1016\/j.ejpb.2026.115259_b0900","doi-asserted-by":"crossref","unstructured":"Shi, Y. and L. Li, Research Advances in Therapeutic Strategies and Drug Delivery Systems for Pathological Scars. Pharmaceutics, 2026 Jan 23. 18(2).","DOI":"10.3390\/pharmaceutics18020148"},{"key":"10.1016\/j.ejpb.2026.115259_b0905","doi-asserted-by":"crossref","unstructured":"Yang, S.-w., et al., Comparison of the histological morphology between normal skin and scar tissue. Journal of Huazhong University of Science and Technology [Medical Sciences] 2016 36:2, 2016-04-13. 36(2).","DOI":"10.1007\/s11596-016-1578-7"},{"issue":"6","key":"10.1016\/j.ejpb.2026.115259_b0910","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2017.06.009","article-title":"Reference values for skin microanatomy: a systematic review and meta-analysis of exvivo studies","volume":"77","author":"Xu","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ejpb.2026.115259_b0955","doi-asserted-by":"crossref","DOI":"10.1016\/j.onano.2022.100064","article-title":"Nanostructured lipid carriers and their potential applications for versatile drug delivery via oral administration","volume":"8","author":"Nguyen","year":"2022","journal-title":"OpenNano"},{"key":"10.1016\/j.ejpb.2026.115259_b0960","first-page":"27(4)","article-title":"A Review of Liposomes as a Drug delivery System: Current Status of Approved Products, Regulatory Environments, and Future Perspectives","volume":"Feb 17","author":"Liu","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejpb.2026.115259_b0965","doi-asserted-by":"crossref","unstructured":"Eltaib, L., et al., Nanotechnologies for Skin Drug Delivery: Polymeric, Bio-Based, and Hybrid Nanocarriers with Clinical and Translational Perspectives. Pharmaceuticals 2026, Vol. 19, Page 1057, 2026-07-08. 19(7).","DOI":"10.3390\/ph19071057"},{"key":"10.1016\/j.ejpb.2026.115259_b0970","doi-asserted-by":"crossref","DOI":"10.3390\/cosmetics11060191","article-title":"Liposomes and Ethosomes: Comparative potential in Enhancing Skin Permeability for Therapeutic and Cosmetic applications","volume":"11","author":"Musielak","year":"2024","journal-title":"Cosmetics"},{"issue":"12","key":"10.1016\/j.ejpb.2026.115259_b0975","doi-asserted-by":"crossref","DOI":"10.1080\/17425247.2021.2011857","article-title":"Solid lipid nanoparticles and nanostructured lipid carrier-based nanotherapeutics for the treatment of psoriasis","volume":"18","author":"Katari","year":"2021","journal-title":"Expert Opin. Drug Deliv."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115259_b0980","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14020383","article-title":"Novel Dermal delivery Cargos of Clobetasol Propionate: an Update - PubMed","volume":"14","author":"Nair","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115259_b0985","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2015.10.003","article-title":"From nanoemulsions to nanostructured lipid carriers: a relevant development in dermal delivery of drugs and cosmetics","volume":"32","author":"Montenegro","year":"2016","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.ejpb.2026.115259_b0915","doi-asserted-by":"crossref","unstructured":"Ding, J.-Y., et al., Nano drug delivery systems: a promising approach to scar prevention and treatment. Journal of Nanobiotechnology, 2023 Aug 11. 21(1).","DOI":"10.1186\/s12951-023-02037-4"},{"key":"10.1016\/j.ejpb.2026.115259_b0920","doi-asserted-by":"crossref","unstructured":"Aung, T. and S. Aung, Selection of an effective topical corticosteroid - PubMed. Australian journal of general practice, 2021 Sep. 50(9).","DOI":"10.31128\/AJGP-07-20-5507"},{"issue":"27","key":"10.1016\/j.ejpb.2026.115259_b0925","doi-asserted-by":"crossref","DOI":"10.2174\/1381612826666200526145706","article-title":"Solid Lipid Nanoparticles for Topical Drug delivery: Mechanisms, Dosage Form Perspectives, and Translational Status","volume":"26","author":"Liu","year":"2020","journal-title":"Curr. Pharm. Des."},{"issue":"5","key":"10.1016\/j.ejpb.2026.115259_b0930","doi-asserted-by":"crossref","DOI":"10.1046\/j.1523-1747.2003.12131.x","article-title":"Determination of the effect of Lipophilicity on the in vitro Permeability and Tissue Reservoir Characteristics of Topically Applied Solutes in Human Skin Layers","volume":"120","author":"Cross","year":"2003","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115259_b0990","doi-asserted-by":"crossref","DOI":"10.1208\/s12249-024-02997-2","article-title":"Understanding Microemulsions and Nanoemulsions in (Trans)Dermal delivery - PubMed","volume":"26","author":"Musakhanian","year":"2025","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2026.115259_b0995","article-title":"Exploring the landscape of Lipid Nanoparticles (LNPs): a comprehensive review of LNPs types and biological sources of lipids","volume":"8","author":"Alfutaimani","year":"2024","journal-title":"International Journal of Pharmaceutics: X"},{"key":"10.1016\/j.ejpb.2026.115259_b1000","doi-asserted-by":"crossref","unstructured":"Basso, J., et al., A Stepwise Framework for the Systematic Development of Lipid Nanoparticles. Biomolecules, 2022 Jan 27. 12(2).","DOI":"10.3390\/biom12020223"},{"key":"10.1016\/j.ejpb.2026.115259_b1005","doi-asserted-by":"crossref","DOI":"10.2147\/IJN.S586727","article-title":"Design Evolution of Curcumin-Loaded Nanostructured Lipid Carriers: Formulation strategies, Functional modifications, and Mechanistic\u2013Translational Perspectives","volume":"21","author":"Nurohman","year":"2026","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejpb.2026.115259_b0935","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2024.08.021","article-title":"Prolonged release from lipid nanoemulsions by modification of drug lipophilicity","volume":"374","author":"Baumann","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2026.115259_b0940","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2025.103402","article-title":"On the formation and stability mechanisms of diverse lipid-based nanostructures for drug delivery","volume":"338","author":"Shah","year":"2025","journal-title":"Adv. Colloid Interface Sci."},{"issue":"3","key":"10.1016\/j.ejpb.2026.115259_b0945","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsps.2020.01.010","article-title":"The use of quantitative analysis and Hansen solubility parameter predictions for the selection of excipients for lipid nanocarriers to be loaded with water soluble and insoluble compounds","volume":"28","author":"Makoni","year":"2020","journal-title":"Saudi Pharmaceutical Journal"},{"key":"10.1016\/j.ejpb.2026.115259_b0950","doi-asserted-by":"crossref","unstructured":"Li, Q., et al., A Review of the Structure, Preparation, and Application of NLCs, PNPs, and PLNs. Nanomaterials, 2017 May 27. 7(6).","DOI":"10.3390\/nano7060122"},{"issue":"D1","key":"10.1016\/j.ejpb.2026.115259_b1010","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkad1004","article-title":"The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods","volume":"52","author":"Zdrazil","year":"2024","journal-title":"Nucleic Acids Res."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2026.115259_b1015","article-title":"Drug interaction and location in liposomes: correlation with polar surface areas","volume":"292","author":"Maghraby","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115259_b1020","article-title":"Formulation design, production and characterisation of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for the encapsulation of a model hydrophobic active. Food Hydrocolloids for","volume":"1","author":"Sakellari","year":"2021","journal-title":"Health"},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2026.115259_b1025","article-title":"Hydrocortisone and dexamethasone in very deformable drug carriers have increased biological potency, prolonged effect, and reduced therapeutic dosage - PubMed","volume":"1663","author":"Cevc","year":"2004","journal-title":"BBA"},{"issue":"3","key":"10.1016\/j.ejpb.2026.115259_b1030","doi-asserted-by":"crossref","DOI":"10.1111\/bcpt.13759","article-title":"Application of Emax model to assess the potency of topical corticosteroid products","volume":"131","author":"Rath","year":"2022","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"6","key":"10.1016\/j.ejpb.2026.115259_b1035","doi-asserted-by":"crossref","DOI":"10.4103\/0253-7613.103267","article-title":"Comparison of reservoir effect of topical corticosteroids in an experimental animal model by histamine-induced wheal suppression test","volume":"44","author":"Abidi","year":"2012","journal-title":"Indian Journal of Pharmacology"},{"issue":"3","key":"10.1016\/j.ejpb.2026.115259_b1040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2007.08.007","article-title":"Bioavailability and bioequivalence of topical glucocorticoids","volume":"68","author":"Wiedersberg","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2026.115259_b1045","article-title":"Pharmaceutical product development: a quality by design approach. International","author":"Pramod","year":"2016","journal-title":"J. Pharm. Investig."},{"issue":"6","key":"10.1016\/j.ejpb.2026.115259_b1050","article-title":"Quality by design based development of nanostructured lipid carrier: a risk based approach","volume":"3","author":"Alam","year":"2022","journal-title":"Exploration of Medicine"},{"issue":"4","key":"10.1016\/j.ejpb.2026.115259_b1055","doi-asserted-by":"crossref","DOI":"10.2174\/1567201813666160512145954","article-title":"Safety Assessment of Tretinoin Loaded Nano Emulsion and Nanostructured Lipid Carriers: a Non-invasive Trial on Human Volunteers","volume":"14","author":"Nasrollahi","year":"2017","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.ejpb.2026.115259_b1060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119480","article-title":"Nanostructured lipid carriers loaded with Halobetasol propionate for topical treatment of inflammation: Development, characterization, biopharmaceutical behavior and therapeutic efficacy of gel dosage forms","volume":"585","author":"Carvajal-Vidal","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"9","key":"10.1016\/j.ejpb.2026.115259_b1065","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12090862","article-title":"Serine Protease-Mediated Cutaneous Inflammation: Characterization of an Ex Vivo Skin Model for the Assessment of Dexamethasone-Loaded Core Multishell-Nanocarriers - PubMed","volume":"12","author":"Frombach","year":"2020","journal-title":"Pharmaceutics"},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2026.115259_b1070","article-title":"Surfactants from itaconic acid: Toxicity to HaCaT keratinocytes in vitro, micellar solubilization, and skin permeation enhancement of hydrocortisone","volume":"524","author":"Abruzzo","year":"2017","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115259_b1075","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2010.12.037","article-title":"Consequences of systemic absorption of topical glucocorticoids","volume":"65","author":"Nieman","year":"2011","journal-title":"J. Am. Acad. Dermatol."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115259_b1165","doi-asserted-by":"crossref","DOI":"10.1016\/j.dit.2013.02.001","article-title":"In vivo study of clobetasol propionate loaded nanoemulsion for topical application in psoriasis and atopic dermatitis","volume":"5","author":"Alam","year":"2013","journal-title":"Drug Invention Today"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115259_b1085","article-title":"Enhancement of Anti-Dermatitis potential of Clobetasol Propionate by DHA [Docosahexaenoic Acid] Rich Algal Oil Nanoemulsion Gel","volume":"15","author":"Alam","year":"2016","journal-title":"Iranian Journal of Pharmaceutical Research : IJPR"},{"issue":"12","key":"10.1016\/j.ejpb.2026.115259_b1080","article-title":"Electrospun proliposomes and the quest to overcome liposome instability","volume":"30","author":"Yadav","year":"2025","journal-title":"Drug Discov. Today"},{"issue":"11","key":"10.1016\/j.ejpb.2026.115259_b1110","doi-asserted-by":"crossref","DOI":"10.3390\/gels8110746","article-title":"In Vitro and Ex Vivo Evaluation of Fluocinolone Acetonide-Acitretin-Coloaded Nanostructured Lipid Carriers for Topical Treatment of Psoriasis","volume":"8","author":"Raza","year":"2022","journal-title":"Gels"},{"key":"10.1016\/j.ejpb.2026.115259_b1115","doi-asserted-by":"crossref","DOI":"10.1016\/j.steroids.2015.05.012","article-title":"Design, characterization and skin permeating potential of Fluocinolone acetonide loaded nanostructured lipid carriers for topical treatment of psoriasis","volume":"101","author":"Pradhan","year":"2015","journal-title":"Steroids"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115259_b1100","article-title":"Preparation of skin friendly topical gel containing betamethasone dipropionate loaded ethosomes and salicylic acid for the treatment of eczema","volume":"8","author":"Khan","year":"2024","journal-title":"Journal of Contemporary Pharmacy"},{"issue":"2","key":"10.1016\/j.ejpb.2026.115259_b1105","doi-asserted-by":"crossref","DOI":"10.1080\/09546634.2020.1789043","article-title":"Mometasone furoate-loaded aspasomal gel for topical treatment of psoriasis: formulation, optimization, invitro and invivo performance","volume":"33","author":"Shinde","year":"2022","journal-title":"J. Dermatol. Treat."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115259_b1170","article-title":"Development of a topical ointment of betamethasone dipropionate loaded nanostructured lipid carrier","volume":"11","author":"Kong","year":"2016","journal-title":"Asian J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115259_b1135","article-title":"Formulation and Evaluation of Hydrocortisone Acetate Loaded Nanostructured Lipid Carriers (NLCs) in Hydrogel for the Treatment of Psoriasis","volume":"18","author":"Chauhan","year":"2025","journal-title":"International Journal of Pharmaceutical Sciences and Nanotechnology(IJPSN)"},{"issue":"5","key":"10.1016\/j.ejpb.2026.115259_b1090","doi-asserted-by":"crossref","DOI":"10.1039\/D5PM00048C","article-title":"Clobetasol propionate and pramoxine hydrochloride loaded nanolipid carrier gel for the treatment of atopic dermatitis","volume":"2","author":"Suresh","year":"2025","journal-title":"RSC Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115259_b1095","article-title":"A novel composite of micelles and hydrogel for improving skin delivery of hydrocortisone and application in atopic dermatitis therapy","volume":"19","author":"Yuan","year":"2020","journal-title":"Appl. Mater. Today"},{"key":"10.1016\/j.ejpb.2026.115259_b1120","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jddst.2017.07.024","article-title":"Fabrication, optimization and characterization of Triamcinolone acetonide loaded nanostructured lipid carriers for topical treatment of psoriasis: Application of Box Behnken design, in vitro and ex vivo studies","volume":"41","author":"Pradhan","year":"2017","journal-title":"J. Drug Delivery Sci. Technol."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115259_b1125","doi-asserted-by":"crossref","DOI":"10.3109\/21691401.2014.955105","article-title":"Influence of selected variables on fabrication of Triamcinolone acetonide loaded solid lipid nanoparticles for topical treatment of dermal disorders","volume":"44","author":"Pradhan","year":"2016","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.ejpb.2026.115259_b1130","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2020.102282","article-title":"Topical delivery of fluocinolone acetonide integrated NLCs and salicylic acid enriched gel: a potential and synergistic approach in the management of psoriasis","volume":"61","author":"Pradhan","year":"2021","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.ejpb.2026.115259_b1140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2020.101594","article-title":"Design, optimization and characterization of novel topical formulations containing Triamcinolone Acetonide","volume":"58","author":"Sa\u011f\u0131ro\u011flu","year":"2020","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.ejpb.2026.115259_b1145","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2016.00071","article-title":"Frontiers | the Efficacy of Triamcinolone Acetonide in Keloid Treatment: a Systematic Review and Meta-analysis","volume":"3","author":"Wong","year":"2016","journal-title":"Front. Med."},{"issue":"5","key":"10.1016\/j.ejpb.2026.115259_b1150","doi-asserted-by":"crossref","DOI":"10.1016\/j.burns.2021.02.013","article-title":"The safety and efficacy of intralesional triamcinolone acetonide for keloids and hypertrophic scars: a systematic review and meta-analysis","volume":"47","author":"Zhuang","year":"2021","journal-title":"Burns"},{"key":"10.1016\/j.ejpb.2026.115259_b1155","doi-asserted-by":"crossref","unstructured":"Murakami, T., et al., Pharmacotherapy for Keloids and Hypertrophic Scars. International Journal of Molecular Sciences 2024, Vol. 25,, 2024-04-25. 25(9).","DOI":"10.3390\/ijms25094674"},{"key":"10.1016\/j.ejpb.2026.115259_b1160","article-title":"A multifunctional microneedle patch loading exosomes and magnetic nanoparticles synergistically for treating oral mucosal lesions","volume":"40","author":"Chen","year":"2024","journal-title":"Appl. Mater. Today"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115259_b1175","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12951-020-00635-0","article-title":"Flexible liposomal gel dual-loaded with all-trans retinoic acid and betamethasone for enhanced therapeutic efficiency of psoriasis","volume":"18","author":"Wang","year":"2020","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ejpb.2026.115259_b1180","doi-asserted-by":"crossref","unstructured":"Yu, L.X. and L.X. Yu, Pharmaceutical Quality by Design: Product and Process Development, Understanding, and Control. Pharmaceutical Research 2007 25:4, 2008-01-10. 25(4).","DOI":"10.1007\/s11095-008-9667-3"},{"key":"10.1016\/j.ejpb.2026.115259_b1185","doi-asserted-by":"crossref","unstructured":"Lionberger, R.A., et al., Quality by Design: Concepts for ANDAs. The AAPS Journal 2008 10:2, 2008-05-09. 10(2).","DOI":"10.1208\/s12248-008-9026-7"},{"issue":"4","key":"10.1016\/j.ejpb.2026.115259_b1190","doi-asserted-by":"crossref","DOI":"10.2478\/acph-2021-0039","article-title":"Quality-by-design in pharmaceutical development: from current perspectives to practical applications","volume":"71","author":"Kov\u00e1cs","year":"2021","journal-title":"Acta Pharm."},{"issue":"22","key":"10.1016\/j.ejpb.2026.115259_b1195","doi-asserted-by":"crossref","DOI":"10.1039\/D5NA00445D","article-title":"Enhancing 3-acetyl-11-keto-\u03b2-boswellic acid skin permeation via nanostructured lipid carriers: integrating quality by design principles for risk estimation and optimization","volume":"7","author":"Priya","year":"2025","journal-title":"Nanoscale Adv."},{"key":"10.1016\/j.ejpb.2026.115259_b1200","doi-asserted-by":"crossref","unstructured":"Patel, V., et al., Quality by design driven development of lipid nanoparticles for cutaneous targeting: a preliminary approach. Drug Delivery and Translational Research 2024 15:4, 2024-08-15. 15(4).","DOI":"10.1007\/s13346-024-01685-9"},{"issue":"11","key":"10.1016\/j.ejpb.2026.115259_b1205","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12111095","article-title":"Manufacturing Considerations for the Development of Lipid Nanoparticles using Microfluidics - PubMed","volume":"12","author":"Roces","year":"2020","journal-title":"Pharmaceutics"},{"issue":"13","key":"10.1016\/j.ejpb.2026.115259_b1210","doi-asserted-by":"crossref","DOI":"10.1021\/acs.nanolett.1c01353","article-title":"Scalable mRNA and siRNA Lipid Nanoparticle Production using a Parallelized Microfluidic Device - PubMed","volume":"21","author":"Shepherd","year":"2021","journal-title":"Nano Lett."},{"key":"10.1016\/j.ejpb.2026.115259_b1215","doi-asserted-by":"crossref","unstructured":"Vogelaar, A., et al., Use of Microfluidics to Prepare Lipid-Based Nanocarriers. Pharmaceutics 2023, Vol. 15,, 2023-03-24. 15(4).","DOI":"10.3390\/pharmaceutics15041053"},{"key":"10.1016\/j.ejpb.2026.115259_b1220","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121762","article-title":"Optimization of large-scale manufacturing of biopolymeric and lipid nanoparticles using microfluidic swirl mixers","volume":"620","author":"Tomeh","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115259_b1225","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2024.106928","article-title":"Establishment of a semi-continuous nano-production line using the Microfluidizer\u00ae technology for the fabrication of lipid-based nanoparticles part 1: Screening of critical parameters and design of experiment optimization studies","volume":"203","author":"Glader","year":"2024","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115259_b1230","doi-asserted-by":"crossref","unstructured":"Glader, C., et al., Process Analytical Strategies for Size Monitoring: Offline, At-Line, Online, and Inline Methods in a Top-Down Nano-Manufacturing Line. Pharmaceutics 2025, Vol. 17,, 2025-05-22. 17(6).","DOI":"10.3390\/pharmaceutics17060684"},{"key":"10.1016\/j.ejpb.2026.115259_b1235","unstructured":"ClinicalTrials.gov [Internet]. National Library of Medicine, National Institutes of Health; [cited 2026 11 September]."},{"issue":"7","key":"10.1016\/j.ejpb.2026.115259_b1240","doi-asserted-by":"crossref","DOI":"10.1080\/17425247.2020.1772750","article-title":"Analytical tools and evaluation strategies for nanostructured lipid carrier-based topical delivery systems","volume":"17","author":"Mahant","year":"2020","journal-title":"Expert Opin. Drug Deliv."},{"issue":"9","key":"10.1016\/j.ejpb.2026.115259_b1245","doi-asserted-by":"crossref","DOI":"10.1248\/bpb.b12-00103","article-title":"Measurement of Skin Permeation\/Penetration of Nanoparticles for their Safety Evaluation","volume":"35","author":"Kimura","year":"2012","journal-title":"Biol. Pharm. Bull."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126002808?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126002808?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T03:14:27Z","timestamp":1793762067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641126002808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":249,"alternative-id":["S0939641126002808"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115259","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rational selection of lipid nanocarriers for topical corticosteroid delivery","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115259","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115259"}}